Aspen Pharmacare Holdings Limited
APNHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.95B
Close$
$5.17
41.9% downside
Current Fair Value
41.9% downsideOvervalued by 41.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.95 Billion |
|---|---|
| Enterprise Value | $3.52 Billion |
| Annual dividend | $0.14 |
| Dividend yield | 1.49% |
| Earnings per Share | $5.96 |
| Beta | 0.34 |
| Outstanding Shares | 443,480,000 |
Return
| Return on Equity | 1.92% |
|---|---|
| Return on Assets | 1.43% |
| Return on Invested Capital | 6.48% |
Valuation & Multiples
| P/E Ratio | 26.16 |
|---|---|
| PEG | -19.38 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.05 |
| Enterprise Value to Revenue | 0.05 |
| Enterprise Value to EBIT | 0.59 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 4.39 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 11, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aspen Pharmacare Holdings Ltd
9,557 employees
CEO: Stephen Saad
Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities...